Globus Medical Inc
Change company Symbol lookup
Select an option...
GMED Globus Medical Inc
WMT WALMART STORES INC
DX Dynex Capital Inc
BMO Bank of Montreal
FPRX Five Prime Therapeutics Inc
VTR Ventas Inc
PENN Penn National Gaming Inc
SUN Sunoco LP
SWKS Skyworks Solutions Inc
VOO Vanguard S&P 500 ETF
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.

Closing Price
$53.74
Day's Change
-1.06 (-1.93%)
Bid
--
Ask
--
B/A Size
--
Day's High
54.71
Day's Low
53.26
Volume
(Average)
Volume:
559,650

10-day average volume:
607,687
559,650

PPG sees Q3 sales down less than expected after July beats its expectations

8:28 am ET August 11, 2020 (MarketWatch)
Print

PPG Industries Inc. (PPG) said Tuesday July sales exceeded its original estimates, as the sales recovery seen in June continued. The paints maker is now expecting third-quarter sales to be down 6% to 11%, compared with a prior forecast of down 8% to 15%. The FactSet consensus is for third-quarter sales of $3.411 billion, which would be down 11% from a year ago. "Led by improving demand trends in our Chinese and European businesses across a variety of coatings end-use markets and in global industrial production, our July sales increased sequentially from the month of June and were down 7% compared to the prior year." Chief Executive Michael H. McGarry said in a statement. Shares rose 3% premarket, but are down 13% in the year through Monday, while the S&P 500 has gained 4%.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

August 11, 2020 08:28 ET (12:28 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.